These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34307456)

  • 21. Identification of circadian clock genes as regulators of immune infiltration in Hepatocellular Carcinoma.
    Zhang Z; Liang Z; Gao W; Yu S; Hou Z; Li K; Zeng P
    J Cancer; 2022; 13(11):3199-3208. PubMed ID: 36118525
    [No Abstract]   [Full Text] [Related]  

  • 22. Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma.
    Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
    Dig Dis Sci; 2019 Oct; 64(10):2878-2892. PubMed ID: 30949905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
    Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
    Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
    [No Abstract]   [Full Text] [Related]  

  • 24. The diagnostic and prognostic value of H2AFY in hepatocellular carcinoma.
    Ma X; Ding Y; Zeng L
    BMC Cancer; 2021 Apr; 21(1):418. PubMed ID: 33858382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Centromere Protein F (
    Huang Y; Chen X; Wang L; Wang T; Tang X; Su X
    J Cancer; 2021; 12(10):2933-2951. PubMed ID: 33854594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CELSR3 mRNA expression is increased in hepatocellular carcinoma and indicates poor prognosis.
    Gu X; Li H; Sha L; Mao Y; Shi C; Zhao W
    PeerJ; 2019; 7():e7816. PubMed ID: 31608178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isoform diversity in the Arp2/3 complex determines actin filament dynamics.
    Abella JV; Galloni C; Pernier J; Barry DJ; Kjær S; Carlier MF; Way M
    Nat Cell Biol; 2016 Jan; 18(1):76-86. PubMed ID: 26655834
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Lan C; Huang X; Liao X; Zhou X; Peng K; Wei Y; Han C; Peng T; Wang J; Zhu G
    Pharmgenomics Pers Med; 2023; 16():337-355. PubMed ID: 37091827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma.
    Cai C; Zhang Y; Hu X; Hu W; Yang S; Qiu H; Chu T
    Front Oncol; 2021; 11():721644. PubMed ID: 34631549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heat Shock Protein Beta 1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
    Long S; Peng F; Song B; Wang L; Chen J; Shang B
    Int J Gen Med; 2021; 14():5483-5492. PubMed ID: 34531676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of GNA14 in hepatocellular carcinoma indicates an unfavorable prognosis.
    Yu T; Lu S; Xie W
    Oncol Lett; 2020 Jul; 20(1):165-172. PubMed ID: 32565944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive analysis of the expression of chaperonin containing TCP1 subunits (CCTs) and their influence on prognosis in hepatocellular carcinoma.
    Fu R; Jiang S; Guan Z; Li J; Zhang X; Chen H
    Transl Cancer Res; 2020 Mar; 9(3):1867-1883. PubMed ID: 35117534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated Bioinformatics Analysis Identifies Heat Shock Factor 2 as a Prognostic Biomarker Associated With Immune Cell Infiltration in Hepatocellular Carcinoma.
    Fan Y; Hou J; Liu X; Han B; Meng Y; Liu B; Chen F; Shang Y; Cao P; Tan K
    Front Genet; 2021; 12():668516. PubMed ID: 34917120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
    Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
    World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic biomarker MITD1 and its correlation with immune infiltrates in hepatocellular carcinoma (HCC).
    Shen H; Wang Z; Ren S; Wang W; Duan L; Zhu D; Zhang C; Duan Y
    Int Immunopharmacol; 2020 Apr; 81():106222. PubMed ID: 32007795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Significance and Potential Mechanisms of ATP Binding Cassette Subfamily C Genes in Hepatocellular Carcinoma.
    Zhou X; Huang JM; Li TM; Liu JQ; Wei ZL; Lan CL; Zhu GZ; Liao XW; Ye XP; Peng T
    Front Genet; 2022; 13():805961. PubMed ID: 35342392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carcinogenesis effects of E2F transcription factor 8 (E2F8) in hepatocellular carcinoma outcomes: an integrated bioinformatic report.
    Lü Y; Zhang J; Li L; Li S; Yang Z
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 31990034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystal structure of Arp2/3 complex.
    Robinson RC; Turbedsky K; Kaiser DA; Marchand JB; Higgs HN; Choe S; Pollard TD
    Science; 2001 Nov; 294(5547):1679-84. PubMed ID: 11721045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic implications of alcohol dehydrogenases in hepatocellular carcinoma.
    Liu X; Li T; Kong D; You H; Kong F; Tang R
    BMC Cancer; 2020 Dec; 20(1):1204. PubMed ID: 33287761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.